Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference72 articles.
1. Gharebaghi R, Heidary F. COVID-19 and Iran: swimming with hands tied! Swiss Med Wkly. 2020;150:w20242. https://doi.org/10.4414/smw.2020.20242.
2. Crump A, Ōmura S. Ivermectin, ‘wonder drug’ from Japan: the human use perspective. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87:13–28. https://doi.org/10.2183/pjab.87.13.
3. Kircik LH, Del Rosso JQ, Layton AM, Schauber J. Over 25 years of clinical experience with ivermectin: an overview of safety for an increasing number of indications. J Drugs Dermatol. 2016;15:325–32.
4. Gonzalez Canga A, et al. The pharmacokinetics and interactions of ivermectin in humans–a mini-review. AAPS J. 2008;10:42–6. https://doi.org/10.1208/s12248-007-9000-9.
5. Kumar BS, Jeyaraman M, Jain R, Anudeep TC. A wonder drug in the arsenal against COVID—19: medication evidence from ivermectin. J Adv Med Med Res. 2020;32:30–7.
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献